Ascendia

  MARKET NEWS

Hovione & Microinnova Partner to Advance Modular Flow Chemistry for Multi-Purpose Manufacturing
Mstack Launches Chemstack AI - A Revolutionary AI-led R&D Platform
eXmoor Pharma & Siam Bioscience Form Strategic Partnership to Establish Leading Cell & Gene Therapy Services
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
Nanexa Receives Japanese Patent Approval for Specific PharmaShell Structure
 FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder
 Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase 2 Study
Abzena Enhances AbZelectPRO Cell Line Offering With New GS Knockout Platforms
Evonik Launches MaxiPure Polysorbate 80 for Injectable Drug Formulations
Kensana Health Lands $120 Million From GEM, Fueling a Global Plant Based Medicine Revolution
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL for the Treatment of Hypercholesterolemia

  EXPERT CONTENT & RESOURCES

CAPMUL GDO (Glycerol Dioleate) is a Versatile Excipient for Pharmaceutical Formulations

CAPMUL GDO (Glycerol Dioleate) is a Versatile Excipient for Pharmaceutical Formulations

ABITEC is excited to present its latest excipient, CAPMUL GDO, Glycerol Dioleate.  CAPMUL GDO is a high-purity, highly versatile functional lipid

The Benefits of Transparent Pricing: How to Compare CMO Proposals & Know What Your True Costs Will Be

The Benefits of Transparent Pricing: How to Compare CMO Proposals & Know What Your True Costs Will Be

We want your experience as a pharmaceutical professional responsible for evaluating and selecting a CMO to be different. This article will help you be prepared when choosing a CMO from among multiple candidates.

  FEATURED EDITORIAL

  COMPANY PROFILE

ProMed Pharma is your distinguished development partner in long-acting injectable and implantable dosage forms. With nearly 20 years of operational history, we have honed our expertise in polymer-based dosage forms, achieving mastery in extended-release dosing. Our proficiency spans molding, extrusion, and microencapsulation techniques, leveraging a diverse spectrum of polymeric excipients encompassing silicones, thermoplastics, and biodegradables. At ProMed Pharma, our commitment to rapid project execution is underpinned by a steadfast dedication to scientific inquiry and technical finesse. Whether you represent an emerging biotech venture or a global pharmaceutical entity, entrust us as your CDMO partner, as we diligently translate scientific concepts into finished dosage forms. Click here for more.

  WHITEPAPERS & WEBINARS

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

In this talk we illustrate several case studies demonstrating how a fundamental understanding of molecular properties combined with a strategic vision for drug product design can lead to effective and advanceable formulations for even the most challenging drug products.

vytal webinar

WEBINAR - Vytal: The RTU Snap-Fit System for Container Closure Solutions – Setting the Standard for the Future

In recent decades, the landscape of parenteral drug production has undergone significant transformation, driven by the emergence of novel molecules and advanced therapies. The pharmaceutical industry has witnessed a notable shift towards biologics, mAbs, and cell-based therapies, which now represent some of the most successful pharmaceutical products globally.

  WHITEPAPERS & WEBINARS

Outsourcing Drug Development & Production: Technology-Driven Drug Delivery Systems for Small Molecules at Losan Pharma

Outsourcing Drug Development & Production: Technology-Driven Drug Delivery Systems for Small Molecules at Losan Pharma

 

By: Matthias Rischer, PhD, Director Drug Delivery & Innovation Projects, and Jens Morgenthaler, PhD, Managing Director

Introduction

In 2021, the global CDMO market is estimated to be $124 billion and is expected to grow at a CAGR of 7% …

WHITEPAPER - Drug Delivery – Recent Trends, Enabling Technologies, In-Vitro-In-Vivo Predictions & Personalized Medicine

WHITEPAPER - Drug Delivery – Recent Trends, Enabling Technologies, In-Vitro-In-Vivo Predictions & Personalized Medicine

By: Dr. Jens Morgenthaler, General Manager and Dr. Matthias Rischer, Head of Innovation, Losan Pharma GmbH

 Introduction

The successful formulation of small molecules is still one of the important challenges of today, especially if these drugs belong to the BioClassificationSystem …

FORMULATION FORUM - A Quick Approach for Evaluation of Drug-Excipient Compatibility: Case of Acetylsalicylic Acid

FORMULATION FORUM - A Quick Approach for Evaluation of Drug-Excipient Compatibility: Case of Acetylsalicylic Acid

INTRODUCTION

Drug-excipient compatibility testing is one of the early formulation screening steps that can help predict a drug product’s stability. Conventional methods for compatibility testing however, are time consuming, labor intensive, require screening several excipients and eventually different formulations. For …